Jonathan Milner is a renowned scientist, entrepreneur, and investor dedicated to advancing life sciences and supporting UK startups. Currently serving as the CEO of bit.bio, Jonathan leads initiatives to transform drug discovery through innovative cell programming technology. Milner founded Abcam, which evolved from a concept into a global enterprise valued over $5 billion, addressing challenges in sourcing reliable research tools. With a Ph.D. in Molecular Genetics from the University of Leicester, Milner has fostered collaboration between academia and industry through the Milner Therapeutics Institute and has invested in over 80 startups, continually driving innovation in the life sciences sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices